5 results
DEFR14A
RNLX
Renalytix Plc
13 Nov 23
Revised proxy
5:15pm
of directors determined by the Board of Directors to be independent.
Board Oversight of Risk Management
Our management is primarily responsible
DEF 14A
RNLX
Renalytix Plc
13 Nov 23
Definitive proxy
9:22am
to be independent.
Board Oversight of Risk Management
Our management is primarily responsible for assessing and managing risk, while our Board of Directors
PRE 14A
RNLX
Renalytix Plc
3 Nov 23
Preliminary proxy
4:04pm
determined by the Board of Directors to be independent.
Board Oversight of Risk Management
Our management is primarily responsible for assessing
6-K
EX-99.1
RNLX
Renalytix Plc
22 Nov 22
Annual Report and For the Year Ended 30 June 2022
5:09pm
in clinical evaluations of new laboratory developed tests and products, institutional review board oversight, regulatory authorizations, and design control
6-K
EX-99.1
RNLX
Renalytix Plc
30 Nov 21
Renalytix plc Annual Report and Financial Statements FOR THE YEAR ENDED 30 JUNE 2021
4:15pm
laboratory developed tests and products, institutional review board oversight, regulatory authorizations, and design control requirements for FDA and EU
- Prev
- 1
- Next